Anebulo Pharmaceuticals Inc
Anebulo Pharmaceuticals Inc Stock, NASDAQ:ANEB
Anebulo Pharmaceuticals, Inc. engages in the provision of pharmaceutical services. The firmÃ¢â?¬â?¢s product candidate is ANEB-001, a potent, small molecule cannabinoid receptor antagonist, designed to address the unmet medical need for a specific antidote for cannabinoid overdose. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.